(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

CHIESI USA, INC.

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: US

Quick snapshot

CHIESI USA, INC.

ST13

US500000086219845

Class

5

Filing

86219845

Registration

5498011

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

Attention: there is active risk

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

68

Latest update

11/21/2024

Classification

Registered

Trademark type

Word

Nice classes

5

Filing date

03/13/2014

Registration date

06/19/2018

Expiration date

-

Recommended action

Perform a full collision analysis and validate classes before any filing or trademark investment.

Next step

These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.

Complete case details

Structured fields from the responsible authority and the official record.

Status date

11/21/2024

Last transaction

11/21/2024

Responsible office

United States Patent and Trademark Office

Status code

702

Official register

Principal Register

Filing basis

Intent to use

First use anywhere

04/28/2014

First use in commerce

04/28/2014

Drawing code

4

Owner type

99

Owner location

Parma, IT

Examiner

EBAUGH, MICHAEL

Current location

Historical data usage

Holders and representatives

Holders

Chiesi Farmaceutici S.p.A.

Representatives

Anthony P. Venturino VORYS, SATER, SEYMOUR AND PEASE LLP

Technical classification

Nice Classes

Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Pharmaceutical preparations and substances for the treatment of cardiovascular disordersrespiratory diseasescardiopulmonaryneurologicalgastrointestinal related diseases and disorders; pharmaceutical preparationshematological agents being pharmaceutical for the treatment of hematological diseases

Publications

History of USPTO decisions and trademark events.

68 publications found

NA85

NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED

11/21/2024

C15A

REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.

11/21/2024

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

11/21/2024

E815

TEAS SECTION 8 & 15 RECEIVED

06/07/2024

REM1

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

06/19/2023

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

01/15/2021

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

01/15/2021

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

01/15/2021

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

01/15/2021

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

01/15/2021

R.PR

REGISTERED-PRINCIPAL REGISTER

06/19/2018

SUNA

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

05/17/2018

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

05/16/2018

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

05/10/2018

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

05/10/2018

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

05/10/2018

DOCK

ASSIGNED TO EXAMINER

02/20/2018

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

11/14/2017

GNRT

NON-FINAL ACTION E-MAILED

11/14/2017

CNRT

SU - NON-FINAL ACTION - WRITTEN

11/14/2017

SUPC

STATEMENT OF USE PROCESSING COMPLETE

10/27/2017

IUAF

USE AMENDMENT FILED

10/24/2017

EISU

TEAS STATEMENT OF USE RECEIVED

10/24/2017

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

04/29/2017

EX5G

SOU EXTENSION 5 GRANTED

04/28/2017

EXT5

SOU EXTENSION 5 FILED

04/24/2017

EEXT

SOU TEAS EXTENSION RECEIVED

04/24/2017

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

11/10/2016

EX4G

SOU EXTENSION 4 GRANTED

11/09/2016

EXT4

SOU EXTENSION 4 FILED

10/19/2016

EEXT

SOU TEAS EXTENSION RECEIVED

10/19/2016

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

05/11/2016

EX3G

SOU EXTENSION 3 GRANTED

05/10/2016

EXT3

SOU EXTENSION 3 FILED

04/12/2016

EEXT

SOU TEAS EXTENSION RECEIVED

04/12/2016

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

10/30/2015

EX2G

SOU EXTENSION 2 GRANTED

10/29/2015

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

10/28/2015

EXT2

SOU EXTENSION 2 FILED

10/19/2015

EEXT

SOU TEAS EXTENSION RECEIVED

10/19/2015

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

04/04/2015

EX1G

SOU EXTENSION 1 GRANTED

04/02/2015

EXT1

SOU EXTENSION 1 FILED

04/02/2015

EEXT

SOU TEAS EXTENSION RECEIVED

04/02/2015

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

10/28/2014

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

09/02/2014

PUBO

PUBLISHED FOR OPPOSITION

09/02/2014

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

08/13/2014

PREV

LAW OFFICE PUBLICATION REVIEW COMPLETED

07/26/2014

ALIE

ASSIGNED TO LIE

07/26/2014

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

07/15/2014

XAEC

EXAMINER'S AMENDMENT ENTERED

07/15/2014

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

07/15/2014

GNEA

EXAMINERS AMENDMENT E-MAILED

07/15/2014

CNEA

EXAMINERS AMENDMENT -WRITTEN

07/15/2014

ZZZX

PREVIOUS ALLOWANCE COUNT WITHDRAWN

07/15/2014

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

07/14/2014

XAEC

EXAMINER'S AMENDMENT ENTERED

07/14/2014

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

07/14/2014

GNEA

EXAMINERS AMENDMENT E-MAILED

07/14/2014

CNEA

EXAMINERS AMENDMENT -WRITTEN

07/14/2014

GEAN

NOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED

06/20/2014

GEAP

EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED

06/20/2014

EPEN

COMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION AUTOMATIC ENTRY

06/20/2014

CPEA

EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED

06/20/2014

DOCK

ASSIGNED TO EXAMINER

06/18/2014

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

03/26/2014

NWAP

NEW APPLICATION ENTERED

03/17/2014

Continuous trademark protection

Get notified about every new filing that threatens CHIESI USA, INC. or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.